Formoterol Budesonide Rotacap

Product Description

Budeflo Forte Keyhaler is an advanced inhalation therapy designed for the effective management of asthma and chronic obstructive pulmonary disease (COPD). This combination inhaler contains two potent active ingredients: Budesonide I.P. (400 mcg) and Formoterol Fumarate Dihydrate I.P. (12 mcg), each contributing to improved respiratory function and symptom control.

Budesonide is an inhaled corticosteroid (ICS) that works by reducing inflammation in the airways. It inhibits the release of inflammatory substances, thereby decreasing swelling and irritation in the bronchial tubes. This action helps to prevent asthma attacks and exacerbations of COPD, providing long-term control and improving overall lung function.

Formoterol Fumarate Dihydrate is a long-acting beta-agonist (LABA) that targets beta-2 adrenergic receptors in the bronchial muscles. Activation of these receptors leads to muscle relaxation and bronchodilation, which results in the widening of the airways. Formoterol provides rapid relief from acute symptoms such as wheezing, shortness of breath, and chest tightness, while also maintaining its bronchodilator effect for up to 12 hours.

The combination of Budesonide and Formoterol in the Budeflo Forte Keyhaler offers a dual-action approach for comprehensive asthma and COPD management. Budesonide ensures sustained anti-inflammatory effects, reducing the frequency and severity of symptoms, while Formoterol provides quick and prolonged bronchodilation, enhancing breathing comfort. This synergistic effect not only helps in controlling chronic respiratory conditions but also improves the quality of life for patients. The Budeflo Forte Keyhaler is an effective and reliable solution for those requiring consistent and effective management of asthma and COPD.